Item 8.01. Other Events.
On September 23, 2022, 9 Meters Biopharma, Inc. (the "Company") convened a
special meeting of stockholders (the "Special Meeting"). At that time, there
were not present or represented by proxy a sufficient number of shares of the
Company's common stock to constitute a quorum. Accordingly, the Company
adjourned the Special Meeting without any business being conducted. The
adjourned Special Meeting will reconvene at the the Company's offices at 8480
Honeycutt Road, Suite 120, Raleigh, North Carolina at 8:00 a.m. Eastern Time on
Friday, October 21, 2022.
The close of business on July 25, 2022 will continue to be the record date for
the determination of stockholders of the Company entitled to vote at the Special
Meeting. Stockholders of the Company who have previously submitted their proxy
or otherwise voted and who do not want to change their vote do not need to take
any action.
No changes have been made in the proposal to be voted on by stockholders at the
Special Meeting. The Company encourages all of its stockholders to read the
Company's definitive proxy statement on Schedule 14A, filed with the Securities
and Exchange Commission (the "SEC") on August 2, 2022, (the "Proxy Statement")
which is available free of charge on the SEC's website at www.sec.gov.
During the period of adjournment, the Company will continue to solicit votes
from its stockholders with respect to the proposal set forth in the Proxy
Statement. The Company encourages all stockholders who have not yet voted to do
so before Thursday, October 20, 2022, at 11:59 p.m. Eastern Time.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
9 METERS BIOPHARMA, INC. 
